A dose finding phase II study of Alimta in i.v. continuous infusion in patients with malignant pleural mesothelioma, non small cell lung cancer, pancreatic cancer and breast cancer.
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2011
At a glance
- Drugs Pemetrexed (Primary)
- Indications Breast cancer; Mesothelioma; Non-small cell lung cancer; Pancreatic cancer
- Focus Adverse reactions
- 16 Jun 2011 New trial record